{"id":"https://openalex.org/W7225115011","doi":"https://doi.org/10.1016/j.heliyon.2026.e45696","title":"Long-term cannabidiol treatment in canine refractory epilepsy, associated with situational anxiety: A case report","display_name":"Long-term cannabidiol treatment in canine refractory epilepsy, associated with situational anxiety: A case report","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225115011","doi":"https://doi.org/10.1016/j.heliyon.2026.e45696"},"language":"en","primary_location":{"id":"doi:10.1016/j.heliyon.2026.e45696","doi":"https://doi.org/10.1016/j.heliyon.2026.e45696","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.heliyon.2026.e45696","pdf_url":null,"source":{"id":"https://openalex.org/S2898612692","display_name":"Heliyon","issn_l":"2405-8440","issn":["2405-8440"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","ki-jl-1","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heliyon","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.heliyon.2026.e45696","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037173317","display_name":"Luigi Sacchettino","orcid":"https://orcid.org/0000-0002-4611-085X","observed_orcids":["https://orcid.org/0000-0002-4611-085X"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luigi Sacchettino","raw_affiliation_strings":["Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092396382","display_name":"Viviana Orsola Giuliano","orcid":"https://orcid.org/0009-0006-7150-2827","observed_orcids":["https://orcid.org/0009-0006-7150-2827"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Viviana Orsola Giuliano","raw_affiliation_strings":["Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160381373","display_name":"Beatrice Borrani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beatrice Borrani","raw_affiliation_strings":["Veterinary Practitioner, Citt\u00e0 di Castello, Perugia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veterinary Practitioner, Citt\u00e0 di Castello, Perugia, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069477229","display_name":"Danila d\u2019Angelo","orcid":"https://orcid.org/0000-0003-2903-4039","observed_orcids":["https://orcid.org/0000-0003-2903-4039"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Danila d\u2019Angelo","raw_affiliation_strings":["Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053360345","display_name":"Francesco Napolitano","orcid":"https://orcid.org/0000-0003-0884-1851","observed_orcids":["https://orcid.org/0000-0003-0884-1851"]},"institutions":[{"id":"https://openalex.org/I4210128854","display_name":"CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)","ror":"https://ror.org/033pa2k60","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210128854"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Francesco Napolitano","raw_affiliation_strings":["CEINGE\u2014Biotecnologie Avanzate Franco Salvatore, Naples, Italy","Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0003-0884-1851","affiliations":[{"raw_affiliation_string":"CEINGE\u2014Biotecnologie Avanzate Franco Salvatore, Naples, Italy","institution_ids":["https://openalex.org/I4210128854"]},{"raw_affiliation_string":"Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5053360345"],"corresponding_institution_ids":["https://openalex.org/I4210128854","https://openalex.org/I71267560"],"apc_list":{"value":2270,"currency":"USD","value_usd":2270},"apc_paid":{"value":2270,"currency":"USD","value_usd":2270},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.83852621,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"16","first_page":"e45696","last_page":"e45696"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8842999935150146,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8842999935150146,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.09880000352859497,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11214","display_name":"Human-Animal Interaction Studies","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cannabidiol","display_name":"cannabidiol","score":0.9779999852180481},{"id":"https://openalex.org/keywords/canine-idiopathic-epilepsy","display_name":"canine idiopathic epilepsy","score":0.8339999914169312},{"id":"https://openalex.org/keywords/drug-resistant-epilepsy","display_name":"drug-resistant epilepsy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/state-anxiety","display_name":"state anxiety","score":0.9279999732971191},{"id":"https://openalex.org/keywords/dogs","display_name":"dogs","score":0.6740000247955322},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.9570000171661377},{"id":"https://openalex.org/keywords/potassium-bromide","display_name":"potassium bromide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.6809999942779541},{"id":"https://openalex.org/keywords/nutraceuticals","display_name":"nutraceuticals","score":0.7820000052452087},{"id":"https://openalex.org/keywords/seizure-frequency","display_name":"seizure frequency","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7526000142097473},{"id":"https://openalex.org/C2776895053","wikidata":"https://www.wikidata.org/wiki/Q422917","display_name":"Cannabidiol","level":3,"score":0.7466999888420105},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6740999817848206},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.664900004863739},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.553600013256073},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.5098000168800354},{"id":"https://openalex.org/C2776819090","wikidata":"https://www.wikidata.org/wiki/Q412391","display_name":"Pentylenetetrazol","level":4,"score":0.4350999891757965},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4316999912261963},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.39089998602867126},{"id":"https://openalex.org/C9114305","wikidata":"https://www.wikidata.org/wiki/Q1428317","display_name":"Situational ethics","level":2,"score":0.37860000133514404},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3172000050544739},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.31310001015663147},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.29789999127388},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.2863999903202057},{"id":"https://openalex.org/C3454156","wikidata":"https://www.wikidata.org/wiki/Q1144241","display_name":"Side effect (computer science)","level":2,"score":0.2856000065803528},{"id":"https://openalex.org/C2777056318","wikidata":"https://www.wikidata.org/wiki/Q79817","display_name":"Cannabis","level":2,"score":0.27970001101493835},{"id":"https://openalex.org/C2778793413","wikidata":"https://www.wikidata.org/wiki/Q407241","display_name":"Phenobarbital","level":2,"score":0.27810001373291016},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.27790001034736633},{"id":"https://openalex.org/C2909985455","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Seizure Disorders","level":3,"score":0.27649998664855957},{"id":"https://openalex.org/C3020385749","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Extended release","level":2,"score":0.26840001344680786},{"id":"https://openalex.org/C2986900798","wikidata":"https://www.wikidata.org/wiki/Q5308926","display_name":"Drug treatment","level":2,"score":0.2533000111579895}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.heliyon.2026.e45696","doi":"https://doi.org/10.1016/j.heliyon.2026.e45696","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.heliyon.2026.e45696","pdf_url":null,"source":{"id":"https://openalex.org/S2898612692","display_name":"Heliyon","issn_l":"2405-8440","issn":["2405-8440"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","ki-jl-1","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heliyon","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:09aa8f9ee9d2412684dcaa90a8d0305e","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/09aa8f9ee9d2412684dcaa90a8d0305e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Heliyon, Vol 12, Iss 16, Pp e45696- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.heliyon.2026.e45696","doi":"https://doi.org/10.1016/j.heliyon.2026.e45696","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.heliyon.2026.e45696","pdf_url":null,"source":{"id":"https://openalex.org/S2898612692","display_name":"Heliyon","issn_l":"2405-8440","issn":["2405-8440"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","ki-jl-1","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heliyon","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1595266116","https://openalex.org/W1860822802","https://openalex.org/W1941436389","https://openalex.org/W1941551863","https://openalex.org/W1978437325","https://openalex.org/W2024110519","https://openalex.org/W2067881763","https://openalex.org/W2103372827","https://openalex.org/W2106324565","https://openalex.org/W2252496421","https://openalex.org/W2289773789","https://openalex.org/W2315569879","https://openalex.org/W2327607040","https://openalex.org/W2588833958","https://openalex.org/W2607188176","https://openalex.org/W2744115661","https://openalex.org/W2781755317","https://openalex.org/W2914988604","https://openalex.org/W2943967654","https://openalex.org/W2987897844","https://openalex.org/W3000551275","https://openalex.org/W3046044497","https://openalex.org/W3193691801","https://openalex.org/W4283208335","https://openalex.org/W4288710644","https://openalex.org/W4302007942","https://openalex.org/W4302424891","https://openalex.org/W4318027231","https://openalex.org/W4319442388","https://openalex.org/W4321498837","https://openalex.org/W4377990611","https://openalex.org/W4382791814","https://openalex.org/W4387965764","https://openalex.org/W4390610809","https://openalex.org/W4391057510","https://openalex.org/W4391542981","https://openalex.org/W4392372237","https://openalex.org/W4392659245","https://openalex.org/W4396915452","https://openalex.org/W4402195578","https://openalex.org/W4402451271","https://openalex.org/W4409262645","https://openalex.org/W4410494998","https://openalex.org/W4412414629"],"related_works":["https://openalex.org/W7203759600","https://openalex.org/W2938845592","https://openalex.org/W2943967654","https://openalex.org/W4387965764","https://openalex.org/W4288710644","https://openalex.org/W4302424891","https://openalex.org/W4413191488","https://openalex.org/W4417357998","https://openalex.org/W1992641853","https://openalex.org/W3021604409"],"abstract_inverted_index":{"Idiopathic":[0],"epilepsy":[1,81],"is":[2,20,108],"the":[3,21,61,141,171,176,208,214,217,266,274,282],"most":[4],"common":[5],"neurological":[6],"disorder":[7],"affecting":[8],"pets":[9],"and":[10,38,91,96,118,127,255,278,289],"can":[11],"be":[12],"characterized":[13],"by":[14,182,249],"seizure":[15,40],"occurrence.":[16],"Phenobarbital":[17],"(PB)":[18],"administration":[19,113],"first-choice":[22],"drug":[23],"therapy,":[24,271],"sometimes":[25],"associated":[26],"with":[27,79,86,100,152,286],"potassium":[28],"bromide":[29],"(KBr),":[30],"both":[31],"approved":[32],"in":[33,42,146,245,253,258],"many":[34],"countries,":[35],"to":[36,45,49,60,63,83,130,192,234],"synergize":[37],"improve":[39],"management":[41,283],"dogs":[43],"unresponsive":[44],"monotherapy.":[46],"However,":[47],"up":[48],"30%":[50],"of":[51,72,134,169,178,203,207,220,229,237,269,276,284],"patients":[52,285],"are":[53],"medically":[54],"resistant,":[55],"thus":[56],"drawing":[57],"clinicians'":[58],"attention":[59],"need":[62],"search":[64],"for":[65,281],"new":[66],"therapeutic":[67],"approaches.":[68],"Here,":[69],"a":[70,73,115,131,224,242,256],"case":[71],"3-year-old":[74],"Segugio":[75],"Maremmano":[76],"dog,":[77],"diagnosed":[78],"idiopathic":[80],"refractory":[82,290],"maintenance":[84,132,142],"polytherapy":[85],"PB":[87],"(3":[88],"mg/kg":[89,94,125,136],"BID)":[90,95],"KBr":[92],"(15":[93],"situational":[97,147],"anxiety,":[98],"treated":[99],"full-spectrum":[101],"cannabidiol":[102],"(CBD)":[103],"oil":[104,112],"as":[105,158,205],"an":[106,144,250],"add-on,":[107],"reported.":[109],"The":[110,201,239],"CBD":[111,204],"followed":[114],"\"start":[116],"low":[117],"go":[119],"slow\"":[120],"protocol,":[121],"initiating":[122],"at":[123,140],"0.5":[124],"BID,":[126],"subsequently":[128],"increasing":[129],"dose":[133],"1.5":[135],"TID.":[137],"One-month":[138],"post-therapy":[139],"dose,":[143],"improvement":[145,244,252],"anxiety":[148],"has":[149],"been":[150],"noted,":[151],"no":[153],"significant":[154],"adverse":[155],"effects,":[156],"such":[157],"increased":[159],"sleepiness,":[160],"lethargy,":[161],"ataxia,":[162],"anorexia,":[163],"or":[164],"emesis.":[165],"After":[166],"three":[167],"months":[168,231,236],"follow-up,":[170],"pet":[172],"parents":[173],"reported":[174],"that":[175],"frequency":[177],"seizures":[179],"had":[180],"decreased":[181],"more":[183],"than":[184],"50%,":[185],"ranging":[186],"from":[187],"one":[188,193],"every":[189,194],"20":[190],"days":[191,196],"60\u201380":[195],"(average":[197],"\u2248":[198],"70":[199],"days).":[200],"impact":[202],"part":[206],"integrated":[209,270],"therapy":[210],"was":[211],"monitored":[212],"on":[213,265,273],"patient":[215],"throughout":[216],"follow-up":[218],"period":[219],"18":[221],"months,":[222],"within":[223],"total":[225],"clinical":[226],"observation":[227],"window":[228],"37":[230],"(from":[232],"12":[233],"49":[235],"age).":[238],"data":[240,262],"demonstrated":[241],"substantial":[243],"epileptic":[246],"symptoms,":[247],"accompanied":[248],"overall":[251],"well-being":[254],"reduction":[257],"anxiety.":[259],"Overall,":[260],"our":[261],"shed":[263],"light":[264],"potential":[267],"use":[268],"based":[272],"prescription":[275],"conventional":[277],"nutraceutical":[279],"compounds,":[280],"emotional":[287],"discomfort":[288],"epilepsy.":[291]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-11-03T00:00:00"}